Name | Number of supported studies | Average coverage | |
---|---|---|---|
brain | 16 studies | 37% ± 20% | |
lung | 11 studies | 24% ± 9% | |
peripheral blood | 10 studies | 23% ± 8% | |
eye | 9 studies | 27% ± 11% | |
intestine | 6 studies | 19% ± 6% | |
kidney | 5 studies | 20% ± 4% | |
liver | 5 studies | 35% ± 20% | |
heart | 4 studies | 20% ± 3% | |
adipose | 4 studies | 30% ± 10% | |
bone marrow | 3 studies | 26% ± 11% | |
uterus | 3 studies | 29% ± 13% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
esophagus | 100% | 7608.62 | 1445 / 1445 | 100% | 103.62 | 183 / 183 |
stomach | 100% | 5480.11 | 359 / 359 | 99% | 68.62 | 284 / 286 |
breast | 100% | 7314.85 | 459 / 459 | 99% | 84.77 | 1105 / 1118 |
ovary | 100% | 8340.27 | 180 / 180 | 99% | 40.26 | 425 / 430 |
lung | 100% | 6717.09 | 578 / 578 | 99% | 63.96 | 1140 / 1155 |
intestine | 100% | 6931.48 | 965 / 966 | 99% | 60.30 | 520 / 527 |
uterus | 100% | 8752.57 | 170 / 170 | 98% | 63.61 | 449 / 459 |
brain | 98% | 4566.35 | 2585 / 2642 | 99% | 48.14 | 701 / 705 |
skin | 100% | 14305.08 | 1809 / 1809 | 97% | 76.13 | 457 / 472 |
bladder | 100% | 8140.33 | 21 / 21 | 96% | 54.65 | 484 / 504 |
pancreas | 98% | 3759.75 | 323 / 328 | 96% | 32.94 | 170 / 178 |
prostate | 100% | 6220.70 | 245 / 245 | 94% | 38.26 | 471 / 502 |
thymus | 100% | 6552.96 | 653 / 653 | 93% | 29.85 | 561 / 605 |
kidney | 100% | 4092.58 | 89 / 89 | 81% | 22.99 | 730 / 901 |
adrenal gland | 100% | 6721.27 | 258 / 258 | 77% | 19.41 | 177 / 230 |
liver | 96% | 2716.27 | 218 / 226 | 71% | 19.35 | 289 / 406 |
adipose | 100% | 7373.08 | 1204 / 1204 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 100% | 47.14 | 29 / 29 |
muscle | 100% | 6894.51 | 803 / 803 | 0% | 0 | 0 / 0 |
spleen | 100% | 7188.58 | 241 / 241 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 100% | 81.65 | 45 / 45 |
blood vessel | 100% | 6503.52 | 1334 / 1335 | 0% | 0 | 0 / 0 |
heart | 94% | 4556.65 | 812 / 861 | 0% | 0 | 0 / 0 |
peripheral blood | 90% | 8569.64 | 836 / 929 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 88% | 49.13 | 70 / 80 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_0002326 | Biological process | B cell lineage commitment |
GO_0018105 | Biological process | peptidyl-serine phosphorylation |
GO_0006303 | Biological process | double-strand break repair via nonhomologous end joining |
GO_0032869 | Biological process | cellular response to insulin stimulus |
GO_0007507 | Biological process | heart development |
GO_0045087 | Biological process | innate immune response |
GO_0006302 | Biological process | double-strand break repair |
GO_0010332 | Biological process | response to gamma radiation |
GO_0006974 | Biological process | DNA damage response |
GO_0018107 | Biological process | peptidyl-threonine phosphorylation |
GO_0034462 | Biological process | small-subunit processome assembly |
GO_0033153 | Biological process | T cell receptor V(D)J recombination |
GO_0160049 | Biological process | negative regulation of cGAS/STING signaling pathway |
GO_0097681 | Biological process | double-strand break repair via alternative nonhomologous end joining |
GO_0031648 | Biological process | protein destabilization |
GO_0033152 | Biological process | immunoglobulin V(D)J recombination |
GO_0006338 | Biological process | chromatin remodeling |
GO_1905221 | Biological process | positive regulation of platelet formation |
GO_0042752 | Biological process | regulation of circadian rhythm |
GO_0048660 | Biological process | regulation of smooth muscle cell proliferation |
GO_0033077 | Biological process | T cell differentiation in thymus |
GO_0001933 | Biological process | negative regulation of protein phosphorylation |
GO_0016233 | Biological process | telomere capping |
GO_0043066 | Biological process | negative regulation of apoptotic process |
GO_0050678 | Biological process | regulation of epithelial cell proliferation |
GO_0036211 | Biological process | protein modification process |
GO_0002328 | Biological process | pro-B cell differentiation |
GO_0008630 | Biological process | intrinsic apoptotic signaling pathway in response to DNA damage |
GO_1902036 | Biological process | regulation of hematopoietic stem cell differentiation |
GO_0001756 | Biological process | somitogenesis |
GO_0000723 | Biological process | telomere maintenance |
GO_0045727 | Biological process | positive regulation of translation |
GO_0002218 | Biological process | activation of innate immune response |
GO_0002360 | Biological process | T cell lineage commitment |
GO_0007420 | Biological process | brain development |
GO_0045621 | Biological process | positive regulation of lymphocyte differentiation |
GO_0045648 | Biological process | positive regulation of erythrocyte differentiation |
GO_0000460 | Biological process | maturation of 5.8S rRNA |
GO_0031571 | Biological process | mitotic G1 DNA damage checkpoint signaling |
GO_0006468 | Biological process | protein phosphorylation |
GO_0002327 | Biological process | immature B cell differentiation |
GO_0043065 | Biological process | positive regulation of apoptotic process |
GO_0048511 | Biological process | rhythmic process |
GO_0035234 | Biological process | ectopic germ cell programmed cell death |
GO_2001034 | Biological process | positive regulation of double-strand break repair via nonhomologous end joining |
GO_0045944 | Biological process | positive regulation of transcription by RNA polymerase II |
GO_0005730 | Cellular component | nucleolus |
GO_0032993 | Cellular component | protein-DNA complex |
GO_0016020 | Cellular component | membrane |
GO_0032040 | Cellular component | small-subunit processome |
GO_0032991 | Cellular component | protein-containing complex |
GO_0005654 | Cellular component | nucleoplasm |
GO_0005958 | Cellular component | DNA-dependent protein kinase-DNA ligase 4 complex |
GO_0005829 | Cellular component | cytosol |
GO_0070418 | Cellular component | DNA-dependent protein kinase complex |
GO_0000781 | Cellular component | chromosome, telomeric region |
GO_0000785 | Cellular component | chromatin |
GO_0005667 | Cellular component | transcription regulator complex |
GO_0070419 | Cellular component | nonhomologous end joining complex |
GO_0005634 | Cellular component | nucleus |
GO_0034511 | Molecular function | U3 snoRNA binding |
GO_0019899 | Molecular function | enzyme binding |
GO_0004677 | Molecular function | DNA-dependent protein kinase activity |
GO_0019904 | Molecular function | protein domain specific binding |
GO_0106310 | Molecular function | protein serine kinase activity |
GO_0003690 | Molecular function | double-stranded DNA binding |
GO_0004674 | Molecular function | protein serine/threonine kinase activity |
GO_0004672 | Molecular function | protein kinase activity |
GO_0061629 | Molecular function | RNA polymerase II-specific DNA-binding transcription factor binding |
GO_0005524 | Molecular function | ATP binding |
GO_0003723 | Molecular function | RNA binding |
GO_0005515 | Molecular function | protein binding |
GO_0035979 | Molecular function | histone H2AXS139 kinase activity |
Gene name | PRKDC |
Protein name | non-specific serine/threonine protein kinase (EC 2.7.11.1) Protein kinase, DNA-activated, catalytic subunit DNA-dependent protein kinase catalytic subunit (DNA-PK catalytic subunit) (DNA-PKcs) (EC 2.7.11.1) (DNPK1) (p460) |
Synonyms | HYRC1 HYRC |
Description | FUNCTION: Serine/threonine-protein kinase that acts as a molecular sensor for DNA damage . Involved in DNA non-homologous end joining (NHEJ) required for double-strand break (DSB) repair and V(D)J recombination . Must be bound to DNA to express its catalytic properties . Promotes processing of hairpin DNA structures in V(D)J recombination by activation of the hairpin endonuclease artemis (DCLRE1C) . Recruited by XRCC5 and XRCC6 to DNA ends and is required to (1) protect and align broken ends of DNA, thereby preventing their degradation, (2) and sequester the DSB for repair by NHEJ . Act as a scaffold protein to aid the localization of DNA repair proteins to the site of damage . The assembly of the DNA-PK complex at DNA ends is also required for the NHEJ ligation step . Found at the ends of chromosomes, suggesting a further role in the maintenance of telomeric stability and the prevention of chromosomal end fusion (By similarity). Also involved in modulation of transcription . As part of the DNA-PK complex, involved in the early steps of ribosome assembly by promoting the processing of precursor rRNA into mature 18S rRNA in the small-subunit processome . Binding to U3 small nucleolar RNA, recruits PRKDC and XRCC5/Ku86 to the small-subunit processome . Recognizes the substrate consensus sequence [ST]-Q . Phosphorylates 'Ser-139' of histone variant H2AX, thereby regulating DNA damage response mechanism . Phosphorylates ASF1A, DCLRE1C, c-Abl/ABL1, histone H1, HSPCA, c-jun/JUN, p53/TP53, PARP1, POU2F1, DHX9, FH, SRF, NHEJ1/XLF, XRCC1, XRCC4, XRCC5, XRCC6, WRN, MYC and RFA2 . Can phosphorylate C1D not only in the presence of linear DNA but also in the presence of supercoiled DNA . Ability to phosphorylate p53/TP53 in the presence of supercoiled DNA is dependent on C1D . Contributes to the determination of the circadian period length by antagonizing phosphorylation of CRY1 'Ser-588' and increasing CRY1 protein stability, most likely through an indirect mechanism (By similarity). Plays a role in the regulation of DNA virus-mediated innate immune response by assembling into the HDP-RNP complex, a complex that serves as a platform for IRF3 phosphorylation and subsequent innate immune response activation through the cGAS-STING pathway . Also regulates the cGAS-STING pathway by catalyzing phosphorylation of CGAS, thereby impairing CGAS oligomerization and activation . Also regulates the cGAS-STING pathway by mediating phosphorylation of PARP1 . . |
Accessions | A0A8V8TMR1 ENST00000314191.7 [P78527-1] ENST00000697603.1 ENST00000338368.7 [P78527-2] F5GX40 H0YG84 ENST00000536429.1 ENST00000540819.1 P78527 |